About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 4NCT02312427

DPP-4 Inhibitor and Serum BNP Level of Diabetic Patients With Congestive Heart Failure

We thought to investigate the influence of DPP-4 inhibitor on the serum BNP level of diabetic patients with congestive heart failure. This study consists of two protocols. In the first protocol, diabe...

Lead sponsor: Mitsui Memorial Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Mitsui Memorial Hospital

Collaborators

Mitsukoshi Health and Welfare Foundation

Age

20 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Outpatient arm
•Type 2 diabetes patient with congestive heart failure under treatment with DPP-4 inhibitor (sitagliptin, vildagliptin, alogliptin, linagliptin, teneligliptin, anagliptin or saxagliptin) .
•High serum BNP (100-2000pg/ml).
•Patients who have given informed consent to participation in the study.
•Type 2 diabetes patient who were hospitalized for congestive heart failure.
•Patients who have given informed consent to participation in the study.

Exclusion Criteria

•HbA1c over 9.0%.
•Patients who changed medication within 1 months before inclusion.
•Judged as ineligible by clinical investigators.
•Hospitalization arm
•Patients on insulin therapy.
•Judged as ineligible by clinical investigators.

Related studies

Effect of Personalized Follow-up in Adapted Physical Activities in Subjects With Chronic Heart Failure.

NCT06222762 · Heart Failure

RECRUITINGPhase 1

A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus

NCT07590193 · Diabetes Mellitus, Type 2

Physiological Versus Right Ventricular Outcome Trial Evaluated for Bradycardia Treatment Upgrades

NCT06052475 · Pacing-Induced Cardiomyopathy, Heart Failure

Non-interventional Study on Guideline Directed Medical Therapy for Patients With Heart Failure (HF) in Germany

NCT06675552 · Heart Disease, Heart Failure, and more

A Study to Learn More About the Safety of the Drug Vericiguat in Japanese People With Chronic Heart Failure Who Will be Receiving Vericiguat Under Real-world Conditions

NCT05666518 · Chronic Heart Failure

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 22, 2018Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE4

Enrollment10

Start dateJan 2015

Last updatedMar 22, 2018

Condition

Heart Failure Diabetes Mellitus

Locations shown

Mitsui Memorial Hospital

Taito-ku, Tokyo

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 22, 2018Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions